- Home
- NXL vs ATIF Comparison
NXL vs ATIF Comparison
Compare NXL & ATIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXL
- ATIF
- Stock Information
- Founded
- NXL 2010
- ATIF 2015
- Country
- NXL United States
- ATIF United States
- Employees
- NXL N/A
- ATIF N/A
- Industry
- NXL Medical Specialities
- ATIF Professional Services
- Sector
- NXL Health Care
- ATIF Consumer Discretionary
- Exchange
- NXL Nasdaq
- ATIF Nasdaq
- Market Cap
- NXL 10.0M
- ATIF 9.9M
- IPO Year
- NXL 2022
- ATIF 2019
- Fundamental
- Price
- NXL $4.13
- ATIF $0.65
- Analyst Decision
- NXL Strong Buy
- ATIF
- Analyst Count
- NXL 1
- ATIF 0
- Target Price
- NXL $3.00
- ATIF N/A
- AVG Volume (30 Days)
- NXL 4.3M
- ATIF 22.3K
- Earning Date
- NXL 11-08-2024
- ATIF 11-13-2024
- Dividend Yield
- NXL N/A
- ATIF N/A
- EPS Growth
- NXL N/A
- ATIF N/A
- EPS
- NXL N/A
- ATIF N/A
- Revenue
- NXL $162,078.00
- ATIF $500,000.00
- Revenue This Year
- NXL $51.39
- ATIF N/A
- Revenue Next Year
- NXL $177.11
- ATIF N/A
- P/E Ratio
- NXL N/A
- ATIF N/A
- Revenue Growth
- NXL 26.00
- ATIF N/A
- 52 Week Low
- NXL $0.25
- ATIF $0.58
- 52 Week High
- NXL $4.36
- ATIF $1.50
- Technical
- Relative Strength Index (RSI)
- NXL 68.88
- ATIF 38.18
- Support Level
- NXL $2.40
- ATIF $0.62
- Resistance Level
- NXL $4.36
- ATIF $0.80
- Average True Range (ATR)
- NXL 0.63
- ATIF 0.11
- MACD
- NXL 0.08
- ATIF -0.02
- Stochastic Oscillator
- NXL 79.19
- ATIF 4.76
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
About ATIF ATIF Holdings Limited
ATIF Holdings Ltd is a consulting company. It provides financial and advisory services to small and medium-sized enterprises and also to individual customers and families. The firm also offers Pre-IPO's, and Post-IPO's services. It operates in one operating segment which is the consulting service business. It generates the majority of its revenue from the USA.